722 related articles for article (PubMed ID: 33103530)
1. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
2. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
3. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
4. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
7. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
Liu HH; Yaron D; Piraino AS; Kapelusznik L
Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
[TBL] [Abstract][Full Text] [Related]
8. Bacterial coinfections in COVID-19: an underestimated adversary.
Fattorini L; Creti R; Palma C; Pantosti A; ;
Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
[TBL] [Abstract][Full Text] [Related]
10. Bacterial co-infections with SARS-CoV-2.
Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
[TBL] [Abstract][Full Text] [Related]
12. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
[TBL] [Abstract][Full Text] [Related]
13. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission.
Pettit NN; Nguyen CT; Lew AK; Bhagat PH; Nelson A; Olson G; Ridgway JP; Pho MT; Pagkas-Bather J
BMC Infect Dis; 2021 Jun; 21(1):516. PubMed ID: 34078301
[TBL] [Abstract][Full Text] [Related]
14. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
16. A call for antimicrobial stewardship in patients with COVID-19: a nationwide cohort study in Korea.
Shin DH; Kang M; Song KH; Jung J; Kim ES; Kim HB
Clin Microbiol Infect; 2021 Apr; 27(4):653-655. PubMed ID: 33137513
[No Abstract] [Full Text] [Related]
17. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
Maataoui N; Chemali L; Patrier J; Tran Dinh A; Le Fèvre L; Lortat-Jacob B; Marzouk M; d'Humières C; Rondinaud E; Ruppé E; Montravers P; Timsit JF; Armand-Lefèvre L
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2227-2234. PubMed ID: 33733394
[TBL] [Abstract][Full Text] [Related]
18. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial.
Chen JZ; Hoang HL; Yaskina M; Kabbani D; Doucette KE; Smith SW; Lau C; Stewart J; Remtulla S; Zurek K; Schultz M; Koriyama-McKenzie H; Cervera C
Lancet Infect Dis; 2023 Jun; 23(6):673-682. PubMed ID: 36716763
[TBL] [Abstract][Full Text] [Related]
20. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
